Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors.
paper
Cited
Public
Unavailable
- Authors
- Ehrlich, Marc; Mozafari, Sabah; Glatza, Michael; Starost, Laura; Velychko, Sergiy; Hallmann, Anna-Lena; Cui, Qiao-Ling; Schambach, Axel; Kim, Kee-Pyo; Bachelin, Corinne; Marteyn, Antoine; Hargus, Gunnar; Johnson, Radia Marie; Antel, Jack; Sterneckert, Jared; Zaehres, Holm; SchΓΆler, Hans R; Baron-Van Evercooren, Anne; Kuhlmann, Tanja
- Year
- 2017
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 28246330
- DOI
- 10.1073/pnas.1614412114
- PMCID
- PMC5358375
Rapid and efficient protocols to generate oligodendrocytes (OL) from human induced pluripotent stem cells (iPSC) are currently lacking, but may be a key technology to understand the biology of myelin diseases and to develop treatments for such disorders. Here, we demonstrate that the induction of three transcription factors (SOX10, OLIG2, NKX6.2) in iPSC-derived neural progenitor cells is sufficient to rapidly generate O4 OL with an efficiency of up to 70% in 28 d and a global gene-expression profile comparable to primary human OL. We further demonstrate that iPSC-derived OL disperse and myelinate the CNS of mice during development and after demyelination, are suitable for in vitro myelination assays, disease modeling, and screening of pharmacological compounds potentially promoting oligodendroglial differentiation. Thus, the strategy presented here to generate OL from iPSC may facilitate the studying of human myelin diseases and the development of high-throughput screening platforms for drug discovery.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | 2018 | 29897633 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Characterising processing conditions that artifactually bias human brain tissue transcriptomes. | Yaqubi M et al. | β | 2026 | β |
| Efficient Induction of Oligodendrocyte Lineage From Pluripotent Stem Cells via Temporal Modulation of OLIG2(S147A) and SOX10. | Ishikawa M et al. | β | 2026 | β |
| Forward programming of human pluripotent stem cells to generate glutamatergic and GABAergic neurons in a tri-culture model with astrocytes. | Gu J et al. | β | 2026 | β |
| From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics. | Karbalaee M et al. | β | 2026 | β |
| In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis. | Gacem N et al. | β | 2026 | β |
| Protocol for the generation and xenotransplantation of human induced pluripotent stem cell-derived neural progenitor cells into the mouse forebrain. | McInvale JJ et al. | β | 2026 | β |
| Stepwise Chemically Defined Differentiation of Human iPSCs into Oligodendrocytes with Harvestable Developmental Intermediates. | Parameswaran S | β | 2026 | β |
| Advanced Cellular Models for Neurodegenerative Diseases and PFAS-Related Environmental Risks. | Rotondo D et al. | β | 2025 | β |
| Alpha synuclein-mediated cytoskeletal dysfunction impairs myelination in human oligodendrocytes. | Wihan J et al. | β | 2025 | β |
| An Efficient Electroporation Protocol Supporting In Vitro Studies of Oligodendrocyte Biology. | Ishino Y et al. | β | 2025 | β |
| A novel human organoid model system reveals requirement of TCF4 for oligodendroglial differentiation. | Furlanetto F et al. | β | 2025 | β |
| Are oligodendrocytes bystanders or drivers of Parkinson's disease pathology? | Salazar Campos JM et al. | β | 2025 | β |
| A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms. | Chapleau A et al. | β | 2025 | β |
| CoTF-reg reveals cooperative transcription factors in oligodendrocyte gene regulation using single-cell multi-omics. | Choi JJ et al. | β | 2025 | β |
| Current Applications of Human Pluripotent Stem Cells in Neuroscience Research and Cell Transplantation Therapy for Neurological Disorders. | Verma I et al. | β | 2025 | β |
| Current Development of iPSC-Based Modeling in Neurodegenerative Diseases. | Guo X et al. | β | 2025 | β |
| Development of a Human Preclinical Platform for the Identification of Neuroprotective Compounds. | GonzΓ‘lez RG et al. | β | 2025 | β |
| Dissection of Neurochemical Pathways Across Complexity and Scale. | Abbondanza A et al. | β | 2025 | β |
| Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis. | Zheng C et al. | β | 2025 | β |
| Functional Neurogenomics to Dissect Disease Mechanisms Across Models. | Zheng X et al. | β | 2025 | β |
| Gas1-high quiescent neural stem cells are multipotent and produce oligodendrocytes during aging and after demyelinating injury. | Ding C et al. | β | 2025 | β |
| High-rate mechano-stimulation alters proliferation- and maturation-related signaling of oligodendrocyte precursor cells in a 3D hydrogel. | Yokosawa R et al. | β | 2025 | β |
| Human iPSC-Derived Neuron and Oligodendrocyte Co-culture as a Small-Molecule Screening Assay for Myelination. | Chie SE et al. | β | 2025 | β |
| Interplay Between Aging and Glial Cell Dysfunction: Implications for CNS Health. | GarcΓa-DomΓnguez M | β | 2025 | β |
| iPSC-modelling reveals genetic associations and morphological alterations of oligodendrocytes in schizophrenia. | Chang MH et al. | β | 2025 | β |
| Neuroinflammation: An Oligodendrocentric View. | Festa LK et al. | β | 2025 | β |
| Protocol for assessing myelination by human iPSC-derived oligodendrocytes in Shiverer mouse exΒ vivo brain slice cultures. | Tsarouchas TM et al. | β | 2025 | β |
| Repurposed Drugs to Enhance the Therapeutic Potential of Oligodendrocyte Precursor Cells Derived from Adult Rat Adipose Tissue. | Pascual-Guerra J et al. | β | 2025 | β |
| Revisiting oligodendrocytes in amyotrophic lateral sclerosis using human multicellular stem cell models. | Mouhi S et al. | β | 2025 | β |
| The Interaction between Oligodendrocytes and AΞ² in Alzheimer's Disease. | Wang W et al. | β | 2025 | β |
| To recruit or to graft? Comparing the recruitment of resident non-neuronal cells by lineage reprogramming with engraftment of stem cell-derived neurons for neuronal replacement therapies. | Peterson DA | β | 2025 | β |
| Transcription Factor-Based Differentiation of Pluripotent Stem Cells: Overcoming the Traps of Random Neuronal Fate. | McDaid G et al. | β | 2025 | β |
| A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis. | Fagiani F et al. | β | 2024 | β |
| Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies. | Charmarke-Askar I et al. | β | 2024 | β |
| Conversion of Astrocyte Cell Lines to Oligodendrocyte Progenitor Cells Using Small Molecules and Transplantation to Animal Model of Multiple Sclerosis. | Sharifi-Kelishadi M et al. | β | 2024 | β |
| CRISPR-edited human ES-derived oligodendrocyte progenitor cells improve remyelination in rodents. | Wagstaff LJ et al. | β | 2024 | β |
| Emerging Human Pluripotent Stem Cell-Based Human-Animal Brain Chimeras for Advancing Disease Modeling and Cell Therapy for Neurological Disorders. | Ji Y et al. | β | 2024 | β |
| Harnessing the potential of human induced pluripotent stem cells, functional assays and machine learning for neurodevelopmental disorders. | Yang Z et al. | β | 2024 | β |
| HiPSC-derived 3D neural models reveal neurodevelopmental pathomechanisms of the Cockayne Syndrome B. | Kapr J et al. | β | 2024 | β |
| Human stem cell transplantation models of Alzheimer's disease. | Ifediora N et al. | β | 2024 | β |
| Identity and Maturity of iPSC-Derived Oligodendrocytes in 2D and Organoid Systems. | Zeldich E et al. | β | 2024 | β |
| Mutual interaction of neurons and astrocytes derived from iPSCs with APPΒ V717L mutation developed the astrocytic phenotypes of Alzheimer's disease. | Supakul S et al. | β | 2024 | β |
| Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. | Summers RA et al. | β | 2024 | β |
| Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease. | Back AM et al. | β | 2024 | β |
| Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo. | Krut' VG et al. | β | 2024 | β |
| Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS. | Windener F et al. | β | 2024 | β |
| Remyelination in the Central Nervous System. | Franklin RJM et al. | β | 2024 | β |
| Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's disease. | Rajani RM et al. | β | 2024 | β |
| Stem and progenitor cell-based therapy of myelin disorders. | Goldman SA et al. | β | 2024 | β |
| The use of a SOX10 reporter toward ameliorating oligodendrocyte lineage differentiation from human induced pluripotent stem cells. | Piscopo VEC et al. | β | 2024 | β |
| Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials. | Conklin B et al. | β | 2023 | β |
| Advancing cell therapy for neurodegenerative diseases. | Temple S | β | 2023 | β |
| Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells? | Rodriguez-Jimenez FJ et al. | β | 2023 | β |
| Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment. | Yang Z et al. | β | 2023 | β |
| Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model. | Liu Z et al. | β | 2023 | β |
| Cell-based experimental strategies for myelin repair in multiple sclerosis. | Borda M et al. | β | 2023 | β |
| Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies. | McCaughey-Chapman A et al. | β | 2023 | β |
| Combined 3D bioprinting and tissue-specific ECM system reveals the influence of brain matrix on stem cell differentiation. | Zamponi M et al. | β | 2023 | β |
| Critical points for optimizing long-term culture and neural differentiation capacity of rodent and human neural stem cells to facilitate translation into clinical settings. | Radoszkiewicz K et al. | β | 2023 | β |
| Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke. | Nie L et al. | β | 2023 | β |
| Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis. | Falkai P et al. | β | 2023 | β |
| From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome. | Watson LA et al. | β | 2023 | β |
| Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease. | Young JE et al. | β | 2023 | β |
| Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders. | Michalski C et al. | β | 2023 | β |
| Mechanisms of axonal support by oligodendrocyte-derived extracellular vesicles. | KrΓ€mer-Albers EM et al. | β | 2023 | β |
| Molecular Insights into Cell Type-specific Roles in Alzheimer's Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling. | Qu W et al. | β | 2023 | β |
| Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias. | Putka AF et al. | β | 2023 | β |
| Nanomaterial payload delivery to central nervous system glia for neural protection and repair. | Saksena J et al. | β | 2023 | β |
| Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner. | Papadopoulou MA et al. | β | 2023 | β |
| Oligodendrocytes in human induced pluripotent stem cell-derived cortical grafts remyelinate adult rat and human cortical neurons. | Martinez-Curiel R et al. | β | 2023 | β |
| Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells. | Hong Y et al. | β | 2023 | β |
| Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease. | Marei HE et al. | β | 2023 | β |
| The Journey of iPSC-derived OPCs in Demyelinating Disorders: From <i>In vitro</i> Generation to <i>In vivo</i> Transplantation. | Lohrasbi F et al. | β | 2023 | β |
| Therapeutical growth in oligodendroglial fate induction via transdifferentiation of stem cells for neuroregenerative therapy. | Dwivedi S et al. | β | 2023 | β |
| Transcription factor combinations that define human astrocyte identity encode significant variation of maturity and function. | Baranes K et al. | β | 2023 | β |
| Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges. | Guerreiro S et al. | β | 2023 | β |
| Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders. | Shim G et al. | β | 2023 | β |
| Cell transplantation to repair the injured spinal cord. | Hall A et al. | β | 2022 | β |
| Deterministic programming of human pluripotent stem cells into microglia facilitates studying their role in health and disease. | Speicher AM et al. | β | 2022 | β |
| Direct Conversion to Achieve Glial Cell Fates: Oligodendrocytes and Schwann Cells. | Yun W et al. | β | 2022 | β |
| Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming. | Legault EM et al. | β | 2022 | β |
| Dissecting the complexities of Alzheimer disease with in vitro models of the human brain. | Blanchard JW et al. | β | 2022 | β |
| Emerging cellular themes in leukodystrophies. | Nowacki JC et al. | β | 2022 | β |
| Expression of Lineage Transcription Factors Identifies Differences in Transition States of Induced Human Oligodendrocyte Differentiation. | Raabe FJ et al. | β | 2022 | β |
| Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction. | Sarrazin N et al. | β | 2022 | β |
| Fast generation of forebrain oligodendrocyte spheroids from human embryonic stem cells by transcription factors. | Ma L et al. | β | 2022 | β |
| From Cells to Organs: The Present and Future of Regenerative Medicine. | Wang Y et al. | β | 2022 | β |
| Generation of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion. | Tanabe K et al. | β | 2022 | β |
| High Dose Pharmaceutical Grade Biotin (MD1003) Accelerates Differentiation of Murine and Grafted Human Oligodendrocyte Progenitor Cells In Vivo. | Levy MJF et al. | β | 2022 | β |
| Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases. | Kiris E | β | 2022 | β |
| Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids. | Barak M et al. | β | 2022 | β |
| Human neural cell type-specificΒ extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer's disease brain. | You Y et al. | β | 2022 | β |
| Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma. | Koppenhafer SL et al. | β | 2022 | β |
| Leveraging the Genetic Diversity of Human Stem Cells in Therapeutic Approaches. | Tegtmeyer M et al. | β | 2022 | β |
| Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models. | Bigarreau J et al. | β | 2022 | β |
| OCT4-induced oligodendrocyte progenitor cells promote remyelination and ameliorate disease. | Yun W et al. | β | 2022 | β |
| Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier? | TepavΔeviΔ V et al. | β | 2022 | β |
| Oligodendroglia Generated From Adult Rat Adipose Tissue by Direct Cell Conversion. | Vellosillo L et al. | β | 2022 | β |
| Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling. | Grekhnev DA et al. | β | 2022 | β |
| Pluripotent stem cell strategies for rebuilding the human brain. | Limone F et al. | β | 2022 | β |
| Promising Strategies for the Development of Advanced In Vitro Models with High Predictive Power in Ischaemic Stroke Research. | Van Breedam E et al. | β | 2022 | β |
| Promoting exogenous repair in multiple sclerosis: myelin regeneration. | Bezukladova S et al. | β | 2022 | β |
| Promoting Oligodendrocyte Differentiation from Human Induced Pluripotent Stem Cells by Activating Endocannabinoid Signaling for Treating Spinal Cord Injury. | Gao H et al. | β | 2022 | β |
| Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells. | Pistollato F et al. | β | 2022 | β |
| Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA. | Xu J et al. | β | 2022 | β |
| Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke. | Xu J et al. | β | 2022 | β |
| Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays? | Sala-Jarque J et al. | β | 2022 | β |
| Using MS induced pluripotent stem cells to investigate MS aetiology. | Fortune AJ et al. | β | 2022 | β |
| 3D hydrogel models of the neurovascular unit to investigate blood-brain barrier dysfunction. | Potjewyd G et al. | β | 2021 | β |
| A comprehensive library of human transcription factors for cell fate engineering. | Ng AHM et al. | β | 2021 | β |
| Autologous Induced Pluripotent Stem Cell-Based Cell Therapies: Promise, Progress, and Challenges. | Madrid M et al. | β | 2021 | β |
| Beneficial contribution of induced pluripotent stem cell-progeny to Connexin 47 dynamics during demyelination-remyelination. | Mozafari S et al. | β | 2021 | β |
| Graphene-Based Scaffolds for Regenerative Medicine. | Bellet P et al. | β | 2021 | β |
| Growing Glia: Cultivating Human Stem Cell Models of Gliogenesis in Health and Disease. | Lanjewar SN et al. | β | 2021 | β |
| Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology. | KΓΌhn R et al. | β | 2021 | β |
| Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity. | Chesnut M et al. | β | 2021 | β |
| Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases. | Shahsavani N et al. | β | 2021 | β |
| Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models. | RΓ΅lova T et al. | β | 2021 | β |
| Modeling Neurological Disorders in 3D Organoids Using Human-Derived Pluripotent Stem Cells. | Bose R et al. | β | 2021 | β |
| Neural In Vitro Models for Studying Substances Acting on the Central Nervous System. | Fritsche E et al. | β | 2021 | β |
| Novel <i>in vitro</i> Experimental Approaches to Study Myelination and Remyelination in the Central Nervous System. | Marangon D et al. | β | 2021 | β |
| Novel Tools and Investigative Approaches for the Study of Oligodendrocyte Precursor Cells (NG2-Glia) in CNS Development and Disease. | Galichet C et al. | β | 2021 | β |
| One-step Reprogramming of Human Fibroblasts into Oligodendrocyte-like Cells by SOX10, OLIG2, and NKX6.2. | Chanoumidou K et al. | β | 2021 | β |
| Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells. | Chamling X et al. | β | 2021 | β |
| Single Transcription Factor-Based Differentiation Allowing Fast and Efficient Oligodendrocyte Generation via SOX10 Overexpression. | Neyrinck K et al. | β | 2021 | β |
| SKAP2 as a new regulator of oligodendroglial migration and myelin sheath formation | Ghelman J et al. | β | 2021 | β |
| SKAP2 as a new regulator of oligodendroglial migration and myelin sheath formation. | Ghelman J et al. | β | 2021 | β |
| The application of in vitro-derived human neurons in neurodegenerative disease modeling. | D'Souza GX et al. | β | 2021 | β |
| The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models. | MacDougall G et al. | β | 2021 | β |
| Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia. | Albert K et al. | β | 2021 | β |
| A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids. | Renner H et al. | β | 2020 | β |
| A Guide to Understanding "State-of-the-Art" Basic Research Techniques in Anesthesiology. | Obal D et al. | β | 2020 | β |
| Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model. | Zhong X et al. | β | 2020 | β |
| Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury. | Lacalle-Aurioles M et al. | β | 2020 | β |
| Continuous Immune-Modulatory Effects of Human Olig2+ Precursor Cells Attenuating a Chronic-Active Model of Multiple Sclerosis. | Nishri Y et al. | β | 2020 | β |
| Effects of Biotin on survival, ensheathment, and ATP production by oligodendrocyte lineage cells in vitro. | Cui QL et al. | β | 2020 | β |
| Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis. | Starost L et al. | β | 2020 | β |
| Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions. | Assetta B et al. | β | 2020 | β |
| Generation of oligodendrocytes and establishment of an all-human myelinating platform from human pluripotent stem cells. | GarcΓa-LeΓ³n JA et al. | β | 2020 | β |
| Human Glial Progenitor Cells Effectively Remyelinate the Demyelinated Adult Brain. | Windrem MS et al. | β | 2020 | β |
| Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease. | Garcia-Leon JA et al. | β | 2020 | β |
| <i>In vitro</i> Models of Neurodegenerative Diseases. | Slanzi A et al. | β | 2020 | β |
| Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination. | Galloway DA et al. | β | 2020 | β |
| Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems. | Rehbach K et al. | β | 2020 | β |
| iPSC modeling of rare pediatric disorders. | Freel BA et al. | β | 2020 | β |
| Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases? | Salado-Manzano C et al. | β | 2020 | β |
| Lesion stage-dependent causes for impaired remyelination in MS. | HeΓ K et al. | β | 2020 | β |
| Massively parallel techniques for cataloguing the regulome of the human brain. | Townsley KG et al. | β | 2020 | β |
| Mechanical regulation of oligodendrocyte biology. | Makhija EP et al. | β | 2020 | β |
| Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases? | Hoch-Kraft P et al. | β | 2020 | β |
| Modeling Alzheimer's disease with iPSC-derived brain cells. | Penney J et al. | β | 2020 | β |
| Modeling the complex genetic architectures of brain disease. | Fernando MB et al. | β | 2020 | β |
| Modelling multiple sclerosis using induced pluripotent stem cells. | MartΓnez-Larrosa J et al. | β | 2020 | β |
| Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo. | Mozafari S et al. | β | 2020 | β |
| Neurodegeneration in a dish: advancing human stem-cell-based models of Alzheimer's disease. | Klimmt J et al. | β | 2020 | β |
| Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS. | Gerhards R et al. | β | 2020 | β |
| POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches. | Perrier S et al. | β | 2020 | β |
| Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids. | Yun W et al. | β | 2020 | β |
| Recent progress in translational engineered in vitro models of the central nervous system. | Nikolakopoulou P et al. | β | 2020 | β |
| The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury. | Duncan GJ et al. | β | 2020 | β |
| Transcription Factor-Based Fate Specification and Forward Programming for Neural Regeneration. | Flitsch LJ et al. | β | 2020 | β |
| Aligned Brain Extracellular Matrix Promotes Differentiation and Myelination of Human-Induced Pluripotent Stem Cell-Derived Oligodendrocytes. | Cho AN et al. | β | 2019 | β |
| Amelioration of Amyotrophic Lateral Sclerosis in SOD1<sup>G93A</sup> Mice by M<sub>2</sub> Microglia from Transplanted Marrow. | Epperly MW et al. | β | 2019 | β |
| Cell Replacement Therapy Improves Pathological Hallmarks in a Mouse Model of Leukodystrophy Vanishing White Matter. | Dooves S et al. | β | 2019 | β |
| Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis. | Marro BS et al. | β | 2019 | β |
| Distinct Function-Related Molecular Profile of Adult Human A2B5-Positive Pre-Oligodendrocytes Versus Mature Oligodendrocytes. | Esmonde-White C et al. | β | 2019 | β |
| Examining the fundamental biology of a novel population of directly reprogrammed human neural precursor cells. | Ahlfors JE et al. | β | 2019 | β |
| Human Pluripotent Stem Cells as Tools for Predicting Developmental Neural Toxicity of Chemicals: Strategies, Applications, and Challenges. | Liang S et al. | β | 2019 | β |
| Immunology of oligodendrocyte precursor cells in vivo and in vitro. | Antel JP et al. | β | 2019 | β |
| Induction of immunological tolerance to myelinogenic glial-restricted progenitor allografts. | Li S et al. | β | 2019 | β |
| In Vitro Functional Characterization of Human Neurons and Astrocytes Using Calcium Imaging and Electrophysiology. | Hansen MG et al. | β | 2019 | β |
| Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications. | Essayan-Perez S et al. | β | 2019 | β |
| Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells. | Naphade S et al. | β | 2019 | β |
| Myelin in the Central Nervous System: Structure, Function, and Pathology. | Stadelmann C et al. | β | 2019 | β |
| Next-generation disease modeling with direct conversion: a new path to old neurons. | Traxler L et al. | β | 2019 | β |
| Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction. | Raabe FJ et al. | β | 2019 | β |
| Oligodendrocytes in Development, Myelin Generation and Beyond. | Kuhn S et al. | β | 2019 | β |
| Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro. | Namchaiw P et al. | β | 2019 | β |
| The in vivo timeline of differentiation of engrafted human neural progenitor cells. | Vogel S et al. | β | 2019 | β |
| The K<sub>2P</sub> -channel TASK1 affects Oligodendroglial differentiation but not myelin restoration. | Albrecht S et al. | β | 2019 | β |
| Ultrahigh field imaging of myelin disease models: Toward specific markers of myelin integrity? | Petiet A et al. | β | 2019 | β |
| Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform. | Garcia-Leon JA et al. | β | 2019 | β |
| Clinical implications of myelin regeneration in the central nervous system. | McMurran CE et al. | β | 2018 | β |
| Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing. | Fritsche E et al. | β | 2018 | β |
| Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination. | Abu-Rub M et al. | β | 2018 | β |
| Generation of defined neural populations from pluripotent stem cells. | McComish SF et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. | Li L et al. | β | 2018 | β |
| Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism. | Jung-Klawitter S et al. | β | 2018 | β |
| Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases. | Li L et al. | β | 2018 | β |
| Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells. | Rowland HA et al. | β | 2018 | β |
| Nfat/calcineurin signaling promotes oligodendrocyte differentiation and myelination by transcription factor network tuning. | Weider M et al. | β | 2018 | β |
| Single Site Fluorination of the GM<sub>4</sub> Ganglioside Epitope Upregulates Oligodendrocyte Differentiation. | Kieser TJ et al. | β | 2018 | β |
| SOX10 Single Transcription Factor-Based Fast and Efficient Generation ofΒ Oligodendrocytes from Human Pluripotent Stem Cells. | GarcΓa-LeΓ³n JA et al. | β | 2018 | β |
| Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems. | Raabe FJ et al. | β | 2018 | β |
| The contribution of GTF2I haploinsufficiency to Williams syndrome. | Chailangkarn T et al. | β | 2018 | β |
| BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. | Fard MK et al. | β | 2017 | β |
| Primary Spinal OPC Culture System from Adult Zebrafish to Study Oligodendrocyte Differentiation <i>In Vitro</i>. | Kroehne V et al. | β | 2017 | β |
| Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells. | Prytkova I et al. | β | 2017 | β |